 |
|
| CANCER CHEMOTHERAPY AND BIOLOGICAL RESPONSE MODIFIERS, 20
| |
| | |
|
|
Annual 20
To order this title, and for more information, click here
Edited By
Guiseppe Giaccone, MD, PhD, Department of Medical Oncology, Academic Hospital Vrije Universiteit, Amsterdam, The Netherlands
Richard Schilsky, MD, Associate Dean for Clinical Research, Biological Sciences Division, University of Chicago, Chicago, IL, USA
Paul Sondel, MD, PhD, Departments of Pediatrics, Human Oncology and Genetics, University of Wisconsin; Comprehensive Cancer Center, Madison, WI, USA
Contents
Section 1: Drugs.
Thymidylate Synthase Inhibitors (S. Ackland); New Nucleoside Analogues in Clinical Development
(W. Plunkett); Anthracyclines (L. Gianni); Tubulin Targeting Agents (W.N. Hait); Topoismerase I Interactive Agents (C.F. Stewart); Topoisomerase
II Inhibitors (K. Hande); Farnesyltransferase Inhibitors (A.A. Adjei); Cyclin-Dependent Kinases as Targets for Cancer Therapy (A.M. Senderowicz);
DNA-Binding Agents (Y. Nieto); The Evolving Role of Endocrine Therapy for the Treatment and Prevention of Breast Cancer (W. Gradishar);
New Targets for Cancer Chemotherapy (A.J. Murgo)
Section 2: Biological Response Modifiers.
The Graft-versus-Tumor
Effect and the Escape of Maliganancy from Immune Regulation (A.J. Barrett); Donor Lymphocyte Infusions for Hematopoitic Malignancy (S.
Slavin); Diptheria Toxin Conjugate Therapy of Cancer (A.E. Frankel); Genetically Engineered T Cells as Adoptive Immunotherapy of Cancer
(R.P. Junghans); Integrating IL-12 into Therapeutic Cancer Vaccines (T. Grajewski); Immunotherapy for Breast Cancer (K.L. Knutson); Immunotherapy
of Melanoma (P.B. Chapman); CEA Loaded Dendritic Cell Vaccines (M.A. Morse).
Section 3: Tumours.
Leukemias
and Plasma Cell Myeloma (P. Wiernik); Lymphomas (A. Santoro); Head and Neck Cancer (M. Al-Sarraf); Upper Gastrointestinal Tumors (K.
Aiba).
Cancers of the Large Bowel and Hepatobiliary Tract (T.S. d'Entremont); Malignant Neuroendocrine Tumors (E. Tiensuu); Genitourinary
Malignancies (M.D. Michaelson); Breast Cancer (G. Bonadonna); Melanoma (A. Schneeberger); Sarcomas (J. Verweij); Brain Tumors (L. Ashby);
Biology and Therapy of Malignant Solid Tumors in Childhood (H. van den Berg); Supportive Care (M. Markman); Aids-Associated Malignancies
(M.H. Shah).
Section 4: Lung Cancer.
CT Screening for Lung Cancer (C. Henschke); Biology of Lung Cancer (A.
Guzdar); Combined Modality of Treatment of Lung Cancer (NSCLC and SCLC) (T. Le Chevalier); Update on the Systemic Treatment of Lung Cancer
(G. Giaccone); Novel Therapeutics for Advanced Non-small Cell Lung Cancer (R. Herbst); Novel therapies for the Treatment of Non-small
Cell Lung Cancer (D. Johnson).
| Bibliographic details |
Hardbound, 822 pages, publication date: JUL-2002
ISBN-13: 978-0-444-51090-7
ISBN-10: 0-444-51090-7
Imprint: ELSEVIER
|
| Price and Ordering |
Price:
EUR 190
USD 190
|  |
Books and book related electronic products are priced in US dollars (USD), euro (EUR), and Great Britain Pounds (GBP). USD prices apply to the Americas and Asia Pacific. EUR prices apply in Europe and the Middle East. GBP prices apply to the UK and all other countries.
|
See also information about conditions of sale & ordering procedures, and links to our regional sales offices.
|
049/435
Last update: 30 Nov 2009
|
|
| |
| | |
|
|
| |
Home | Elsevier Sites | Privacy Policy | Terms and Conditions | Feedback | Site Map | A Reed Elsevier Company